• Travel grants for emerging cancer and stem cell researchers
    Previous AMSBIO travel grant winners at ISSCR 2023.
  • Plane approaching San Diego airport.

Research News

Travel grants for emerging cancer and stem cell researchers

Jan 25 2024

In a commitment to fostering scientific advancement, AMSBIO has introduced its Travel Grant Award Scheme for 2024, designed for scientists under thirty years of age engaged in cancer and stem cell research within academia, research institutions, or companies. Building on the success of last year's grant to attend ISSCR 2023, AMSBIO is expanding its support by offering two grant schemes: one for the AACR Annual Meeting 2024 in San Diego, USA, and another for the ISSCR Annual Meeting 2024 in Hamburg, Germany.

This initiative provides two $1,000 grants to young science professionals, assisting with travel-related expenses such as flights, accommodation, entry tickets, and other necessities for attending AACR 2024 (7-10th April) or ISSCR 2024 (11-13th July). Krystyna Joyce, Marketing Manager, expressed enthusiasm, stating: "We know that attending conferences allows scientists to meet leading experts, network with fellow researchers, and learn about new and innovative research, accelerating their career and scientific progress."

To be eligible for the 2024 travel grant schemes, applicants can click here and provide a concise summary of up to 3000 characters describing their current stem cell-related research. Alternatively, those presenting a poster at either meeting can submit their abstracts.

AMSBIO's dedication to advancing stem cell discovery is evident through its provision of essential tools and reagents to help research scientists work more efficiently and obtain reliable results faster. Stem cells, particularly human embryonic stem cells, are a notoriously labile cell type. Without careful attention, these cells tend to spontaneously differentiate and undergo genomic rearrangements in culture. Today, AMSBIO offers researchers an unmatched range of high-performance stem-cell-optimized and qualified growth media, sera, feeder cells, supplements, growth factors, and assay kits.

More information online